Electronic Resource
[s.l.]
:
Nature Publishing Group
Nature biotechnology
24 (2006), S. 874-874
ISSN:
1546-1696
Source:
Nature Archives 1869 - 2009
Topics:
Biology
,
Process Engineering, Biotechnology, Nutrition Technology
Notes:
[Auszug] The return of the multiple sclerosis (MS) drug Tysabri (natalizumab) to the US market, sanctioned by the US Food and Drug Administration (FDA) on June 5, and its first-time approval in the EU, announced on June 29, was welcomed by investors. The move should also eventually lead to a clearer ...
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1038/nbt0806-874
|
Location |
Call Number |
Expected |
Availability |